Enveric Biosciences, Inc.
ENVB
$5.32
$0.224.31%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.79M | 6.13M | 5.90M | 5.93M | 6.45M |
| Depreciation & Amortization | 200.90K | 243.90K | 288.30K | 333.10K | 337.50K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.77M | 9.75M | 9.96M | 9.34M | 9.63M |
| Operating Income | -8.77M | -9.75M | -9.96M | -9.34M | -9.63M |
| Income Before Tax | -8.77M | -9.73M | -9.94M | -9.30M | -9.57M |
| Income Tax Expenses | -- | 7.20K | 7.20K | 7.20K | 8.90K |
| Earnings from Continuing Operations | -8.77 | -9.73 | -9.94 | -9.30 | -9.57 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.77M | -9.73M | -9.94M | -9.30M | -9.57M |
| EBIT | -8.77M | -9.75M | -9.96M | -9.34M | -9.63M |
| EBITDA | -8.57M | -9.51M | -9.68M | -9.01M | -9.29M |
| EPS Basic | -43.17 | -94.63 | -126.92 | -159.86 | -255.80 |
| Normalized Basic EPS | -22.21 | -56.04 | -79.24 | -99.83 | -159.74 |
| EPS Diluted | -43.17 | -94.63 | -126.92 | -159.86 | -255.80 |
| Normalized Diluted EPS | -22.21 | -56.04 | -79.24 | -99.83 | -159.74 |
| Average Basic Shares Outstanding | 1.34M | 734.10K | 469.30K | 295.20K | 167.60K |
| Average Diluted Shares Outstanding | 1.34M | 734.10K | 469.30K | 295.20K | 167.60K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |